Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41591-020-0895-3

http://scihub22266oqcxt.onion/10.1038/s41591-020-0895-3
suck pdf from google scholar
32382154!8272982!32382154
unlimited free pdf from europmc32382154    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32382154      Nat+Med 2020 ; 26 (6): 849-854
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Modeling shield immunity to reduce COVID-19 epidemic spread #MMPMID32382154
  • Weitz JS; Beckett SJ; Coenen AR; Demory D; Dominguez-Mirazo M; Dushoff J; Leung CY; Li G; Magalie A; Park SW; Rodriguez-Gonzalez R; Shivam S; Zhao CY
  • Nat Med 2020[Jun]; 26 (6): 849-854 PMID32382154show ga
  • The COVID-19 pandemic has precipitated a global crisis, with more than 1,430,000 confirmed cases and more than 85,000 confirmed deaths globally as of 9 April 2020(1-4). Mitigation and suppression of new infections have emerged as the two predominant public health control strategies(5). Both strategies focus on reducing new infections by limiting human-to-human interactions, which could be both socially and economically unsustainable in the long term. We have developed and analyzed an epidemiological intervention model that leverages serological tests(6,7) to identify and deploy recovered individuals(8) as focal points for sustaining safer interactions via interaction substitution, developing what we term 'shield immunity' at the population scale. The objective of a shield immunity strategy is to help to sustain the interactions necessary for the functioning of essential goods and services(9) while reducing the probability of transmission. Our shield immunity approach could substantively reduce the length and reduce the overall burden of the current outbreak, and can work synergistically with social distancing. The present model highlights the value of serological testing as part of intervention strategies, in addition to its well-recognized roles in estimating prevalence(10,11) and in the potential development of plasma-based therapies(12-15).
  • |*Models, Biological[MESH]
  • |Adult[MESH]
  • |Age Factors[MESH]
  • |Asymptomatic Infections[MESH]
  • |Basic Reproduction Number[MESH]
  • |COVID-19[MESH]
  • |Communicable Disease Control[MESH]
  • |Coronavirus Infections/epidemiology/*immunology/pathology/prevention & control[MESH]
  • |Hospital Bed Capacity[MESH]
  • |Humans[MESH]
  • |Middle Aged[MESH]
  • |Pandemics/prevention & control[MESH]
  • |Pneumonia, Viral/epidemiology/*immunology/pathology/prevention & control[MESH]
  • |United States/epidemiology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box